Eeyarestatin has been demonstrated to activate ATF3 and ATF4 and to induce the expression of the pro-apoptotic NOXA in malignant melanoma cells, indicating its anti-cancer activity [251,252]. This evidence concerns the gene ATF4 and cancer.